6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gynecologic Manifestations of the DICER1 Syndrome.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients with germline DICER1 mutations are at increased risk of developing a wide range of tumors, most of which are relatively rare in the general population. In the gynecologic tract, these include ovarian sex cord-stromal tumors, particularly Sertoli-Leydig cell tumor, and embryonal rhabdomyosarcoma of the cervix. In some cases, these are the sentinel neoplasms. DICER1-associated tumors may have distinctive morphologic appearances that may prompt the pathologist to consider an underlying tumor predisposition syndrome and therefore consideration of genetic evaluation in the patient and her family.

          Related collections

          Author and article information

          Journal
          Surg Pathol Clin
          Surgical pathology clinics
          Elsevier BV
          1875-9157
          1875-9157
          Jun 2016
          : 9
          : 2
          Affiliations
          [1 ] Department of Histopathology, King Edward Memorial Hospital, School for Women's and Infants' Health, University of Western Australia, Subiaco, Perth, Western Australia 6008, Australia. Electronic address: colin.stewart@health.wa.gov.au.
          [2 ] Department of Anatomical Pathology, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar.
          [3 ] Department of Human Genetics, McGill University, Montreal, Quebec, Canada; Department of Oncology, McGill University, Montreal, Quebec, Canada; Department of Medical Genetics, Jewish General Hospital, McGill University Health Centre, Montreal, Quebec, Canada; Cancer Genetics Laboratory, Lady Davis Institute, Montreal, Quebec H3T 1E2, Canada.
          Article
          S1875-9181(16)00014-3
          10.1016/j.path.2016.01.002
          27241106
          bdd95a69-8e6e-44da-a02e-3e82ed84b76c
          History

          Syndrome,Sertoli-Leydig cell tumor,Rhabdomyosarcoma,Ovary,Mutation,DICER1,Cervix

          Comments

          Comment on this article